Stock NSPR INSPIREMD, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus InspireMD, Inc.

Equities

NSPR

US45779A8466

Market Closed - Nasdaq
Other stock markets
 21:30:01 13/05/2024 BST 		5-day change 1st Jan Change
2.4 USD +7.38% Intraday chart for InspireMD, Inc. +13.20% -14.59%
03-06 Transcript : InspireMD, Inc., Q4 2023 Earnings Call, Mar 06, 2024
03-06 Earnings Flash (NSPR) INSPIREMD Posts Q4 Revenue $1.8M MT

Evolution of the average Target Price on InspireMD, Inc.

Price target over the last 5 years

History of analyst recommendation changes

934be62b.R43e7j4fEib42-ekgaYTYmla4MMowc_2WEU98qJqCAI.PcWGw25IRl_Oo97x6u0gUSsvhvFPgrXGIAB-pdQzUjcwtI-Ib15lYNWtrg~02fc8ada9796c9de937375b989f863d3

Analyst Recommendations on InspireMD, Inc.

Piper Sandler Initiates InspireMD at Overweight With $3 Price Target MT
Alliance Global Adjusts Price Target on InspireMD to $4.75 From $5.15, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.4 USD
Average target price
4.5 USD
Spread / Average Target
+87.51%
High Price Target
4.5 USD
Spread / Highest target
+87.51%
Low Price Target
4.5 USD
Spread / Lowest Target
+87.51%

Consensus detail

Consensus revision (last 18 months)

Analysts covering InspireMD, Inc.

Piper Sandler
Alliance Global Partners

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NSPR Stock
  4. Consensus InspireMD, Inc.